NEW YORK--(BUSINESS WIRE)--Tarsadia Investments, a multibillion-dollar firm that makes high-conviction investments in category-defining companies globally, is proud to announce the expansion of its Venture, Growth & Private Investing (“VGP”) practice with the addition of two industry experts. These accomplished professionals bring invaluable expertise in financial technology, software, and healthcare to the firm, reinforcing Tarsadia's commitment to driving transformative change in these industries.
Sponsored by a permanent capital base, Tarsadia offers entrepreneurs maximum alignment, often partnering over a decade-plus investment horizon. Tarsadia combines deep thematic research with decades of operating experience to make high-conviction investments across multiple stages. Tarsadia’s multi-disciplinary and collaborative approach across venture, private equity, and public markets drives unique insight and support for founders across the business life cycle. Additionally, the firm’s flexible mandate enables creative deal structures, including financing growth, recapitalizations, or acquisitions of significant competitors.
Rikhil Bajaj leads the firm’s VGP investments in financial technology, software, and digital assets. Informed by his experience working with growth stage to scale businesses, Rikhil supports entrepreneurs on topics including growth, talent, and financing/M&A. Prior to Tarsadia, Rikhil was a founding member of the growth equity team at SignalFire, a $1.5B+ venture fund, and part of the senior team at GTCR, a $20B+ private equity firm. Rikhil also worked as a technology and healthcare investor at Warburg Pincus and Primus Capital. Rikhil holds an MBA from The Wharton School at the University of Pennsylvania and a BBA (Honors) from the Schulich School of Business, York University.
Dr. Shubhra Jain leads the firm’s VGP investments in healthcare technology, leveraging her experience as a physician and tech acumen to support founders in building a more equitable, affordable, and effective healthcare ecosystem. Prior to Tarsadia, Dr. Jain built and led a healthcare investment practice at Cota Capital, where she invested in businesses like Berkeley Lights, Zymergen, and Mission Bio. She also has operating experience leading product development and launch at a health-tech startup. Dr. Jain is a primary care physician by background. She also has her M.S. in Engineering from Stanford School of Engineering and her MBA from The Wharton School.
"We are constantly evolving and elevating our team to augment our founder-first DNA," said Rishi Reddy, Managing Director and Head of the VGP practice at Tarsadia Investments. “We are excited to welcome Rikhil Bajaj and Dr. Shubhra Jain to our team. Their investment experience and sector expertise will play a crucial role in our mission to support visionary founders and drive transformative change in these industries."
About Tarsadia Investments, LLC
Tarsadia Investments is a multibillion-dollar private investment management vehicle that makes high-conviction investments in category-defining companies globally. We are a supportive and value-enhancing investment partner and have a history of seeking out and working with exceptional management teams. We’ve invested across stages from idea to public ownership, with often a decade-plus investment horizon. We use our domain expertise in financial services, healthcare, real estate, and technology to support founders on growth, talent, and M&A/capital raising. For more information, please visit https://tarsadia.com/.
